160 related articles for article (PubMed ID: 17416293)
1. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.
Miller M; Rhyne J; Chen H; Beach V; Ericson R; Luthra K; Dwivedi M; Misra A
Arch Med Res; 2007 May; 38(4):444-51. PubMed ID: 17416293
[TBL] [Abstract][Full Text] [Related]
2. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
3. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
4. [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].
Niu T; Jiang M; Liu H; Jiang X; Lin Z; Zhang M; Wang J; Geng N; Xin Y; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):374-9. PubMed ID: 25180874
[TBL] [Abstract][Full Text] [Related]
5. Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
Pollex RL; Ban MR; Young TK; Bjerregaard P; Anand SS; Yusuf S; Zinman B; Harris SB; Hanley AJ; Connelly PW; Huff MW; Hegele RA
BMC Med Genet; 2007 Dec; 8():80. PubMed ID: 18096054
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
Yu J; Huang J; Liang Y; Qin B; He S; Xiao J; Wang H; Zhong R
Lipids Health Dis; 2011 Nov; 10():200. PubMed ID: 22054125
[TBL] [Abstract][Full Text] [Related]
7. Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.
van Hoek M; van Herpt TW; Dehghan A; Hofman A; Lieverse AG; van Duijn CM; Witteman JC; Sijbrands EJ
Diabetologia; 2011 Jun; 54(6):1360-7. PubMed ID: 21373834
[TBL] [Abstract][Full Text] [Related]
8. Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study.
Hosseini-Esfahani F; Mirmiran P; Daneshpour MS; Mehrabi Y; Hedayati M; Soheilian-Khorzoghi M; Azizi F
Br J Nutr; 2015 Feb; 113(4):644-53. PubMed ID: 25653052
[TBL] [Abstract][Full Text] [Related]
9. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.
Lin B; Huang Y; Zhang M; Wang J; Wu Y
BMJ Open; 2014 Jan; 4(1):e004156. PubMed ID: 24430880
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population.
Guettier JM; Georgopoulos A; Tsai MY; Radha V; Shanthirani S; Deepa R; Gross M; Rao G; Mohan V
J Clin Endocrinol Metab; 2005 Mar; 90(3):1705-11. PubMed ID: 15598690
[TBL] [Abstract][Full Text] [Related]
12. Western dietary pattern interaction with APOC3 polymorphism in the risk of metabolic syndrome: Tehran Lipid and Glucose Study.
Hosseini-Esfahani F; Mirmiran P; Daneshpour MS; Mehrabi Y; Hedayati M; Zarkesh M; Azizi F
J Nutrigenet Nutrigenomics; 2014; 7(2):105-17. PubMed ID: 25301527
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
[TBL] [Abstract][Full Text] [Related]
15. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.
Puppala J; Bhrugumalla S; Kumar A; Siddapuram SP; Viswa PD; Kondawar M; Akka J; Munshi A
Indian J Gastroenterol; 2014 Nov; 33(6):524-9. PubMed ID: 25319715
[TBL] [Abstract][Full Text] [Related]
17. Association between Genetic Variant of
Jo G; Kwak SY; Kim JY; Lim H; Shin MJ
Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380775
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins.
Brown S; Ordovás JM; Campos H
Atherosclerosis; 2003 Oct; 170(2):307-13. PubMed ID: 14612212
[TBL] [Abstract][Full Text] [Related]
19. Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage.
Jiang Y; Ma J; Li H; Liu Y; You C
Lipids Health Dis; 2015 May; 14():48. PubMed ID: 25994187
[TBL] [Abstract][Full Text] [Related]
20. Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.
Zhang JZ; Xie X; Ma YT; Zheng YY; Yang YN; Li XM; Fu ZY; Dai CF; Zhang MM; Yin GT; Liu F; Chen BD; Gai MT
Aging Dis; 2016 Jan; 7(1):36-44. PubMed ID: 26816662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
